128 related articles for article (PubMed ID: 32091143)
1. Practices in synagogues regarding Jewish genetic disease education.
Thomsen AJ; Matthews AL; Mitchell AL; Cohen L
J Genet Couns; 2020 Dec; 29(6):1041-1049. PubMed ID: 32091143
[TBL] [Abstract][Full Text] [Related]
2. Recommendation of premarital genetic screening in the Syrian Jewish community based on mutation carrier frequencies within Syrian Jewish cohorts.
Zeevi DA; Chung WK; Levi C; Scher SY; Bringer R; Kahan Y; Muallem H; Benel R; Hirsch Y; Weiden T; Ekstein A; Ekstein J
Mol Genet Genomic Med; 2021 Aug; 9(8):e1756. PubMed ID: 34288589
[TBL] [Abstract][Full Text] [Related]
3. Involvement of rabbis in counseling and referral for genetic conditions: results of a survey.
Steiner-Grossman P; David KL
Am J Hum Genet; 1993 Dec; 53(6):1359-65. PubMed ID: 8250053
[TBL] [Abstract][Full Text] [Related]
4. Implementation of a Carrier Screening Program in a High-Risk Undergraduate Student Population Using Digital Marketing, Online Education, and Telehealth.
Hardy MW; Kener HJ; Grinzaid KA
Public Health Genomics; 2018; 21(1-2):67-76. PubMed ID: 30408784
[TBL] [Abstract][Full Text] [Related]
5. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
Rozenberg R; Pereira Lda V
Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
[TBL] [Abstract][Full Text] [Related]
6. Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program.
Hegwer G; Fairley C; Charrow J; Ormond KE
J Genet Couns; 2006 Feb; 15(1):61-70. PubMed ID: 16468087
[TBL] [Abstract][Full Text] [Related]
7. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
[TBL] [Abstract][Full Text] [Related]
8. Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
Grinzaid KA; Page PZ; Denton JJ; Ginsberg J
J Genet Couns; 2015 Jun; 24(3):381-7. PubMed ID: 25502003
[TBL] [Abstract][Full Text] [Related]
9. Ashkenazi Jewish genetic disease carrier screening.
Begleiter ML; Buchholz JL; Atherton AM; Mays LZ; Lund MM; Strenk ME
Genet Med; 2008 Jun; 10(6):461; author reply 461-2. PubMed ID: 18496229
[No Abstract] [Full Text] [Related]
10. Response to ACMG guideline: carrier screening in individuals of Ashkenazi Jewish decent.
Levy-Lahad E; Zuckerman S; Sagi M
Genet Med; 2008 Jun; 10(6):462; author reply 463. PubMed ID: 18496217
[No Abstract] [Full Text] [Related]
11. Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases.
Warsch JR; Warsch S; Herman E; Zakarin L; Schneider A; Hoffman J; Wasserman D; Barbouth D
J Community Genet; 2014 Jul; 5(3):223-31. PubMed ID: 24415495
[TBL] [Abstract][Full Text] [Related]
12. Prenatal genetic screening in the Ashkenazi Jewish population.
Zinberg RE; Kornreich R; Edelmann L; Desnick RJ
Clin Perinatol; 2001 Jun; 28(2):367-82. PubMed ID: 11499058
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic variant-based preconception carrier screening in the Israeli Jewish population.
Davidov B; Levon A; Volkov H; Orenstein N; Karo R; Fatal Gazit I; Magal N; Basel-Salmon L; Golan Mashiach M
Clin Genet; 2022 May; 101(5-6):517-529. PubMed ID: 35315053
[TBL] [Abstract][Full Text] [Related]
14. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
[TBL] [Abstract][Full Text] [Related]
15. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.
Scott SA; Edelmann L; Liu L; Luo M; Desnick RJ; Kornreich R
Hum Mutat; 2010 Nov; 31(11):1240-50. PubMed ID: 20672374
[TBL] [Abstract][Full Text] [Related]
16. ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent.
Obstet Gynecol; 2009 Oct; 114(4):950. PubMed ID: 19888064
[TBL] [Abstract][Full Text] [Related]
17. The
Ariese P
Int J Herit Stud; 2024; 30(7):799-820. PubMed ID: 38774577
[TBL] [Abstract][Full Text] [Related]
18. Expanded genetic screening panel for the Ashkenazi Jewish population.
Baskovich B; Hiraki S; Upadhyay K; Meyer P; Carmi S; Barzilai N; Darvasi A; Ozelius L; Peter I; Cho JH; Atzmon G; Clark L; Yu J; Lencz T; Pe'er I; Ostrer H; Oddoux C
Genet Med; 2016 May; 18(5):522-8. PubMed ID: 26334176
[TBL] [Abstract][Full Text] [Related]
19. Carrier screening in the Mexican Jewish community using a pan-ethnic expanded carrier screening NGS panel.
Morgenstern-Kaplan D; Raijman-Policar J; Majzner-Aronovich S; Aradhya S; Pineda-Alvarez DE; Aguinaga M; García-Vences EE
Genet Med; 2022 Apr; 24(4):821-830. PubMed ID: 34961661
[TBL] [Abstract][Full Text] [Related]
20. Carrier screening panels for Ashkenazi Jews: is more better?
Leib JR; Gollust SE; Hull SC; Wilfond BS
Genet Med; 2005 Mar; 7(3):185-90. PubMed ID: 15775754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
